{"database": "openregs", "table": "documents", "rows": [["FDA-2014-D-0329-0002", "FDA", "FDA-2014-D-0329", "Fees for Human Drug Compounding Outsourcing Facilities Under Sections 503B and 744K of the FD&C Act Guidance for Industry", "Other", "Guidance", "2014-04-01T04:00:00Z", 2014, 4, "2014-04-01T04:00:00Z", null, "2024-11-07T23:05:24Z", null, 1, 0, "0900006481694c66"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2014-D-0329-0002"], "units": {}, "query_ms": 0.42352802120149136, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}